by Sue Robbins | May 30, 2013 | Headache Drugs
A groundbreaking study by William B. Young, MD, a neurologist at Thomas Jefferson University Hospital’s Headache Center, found that patients with migraine experience social stigma much like people who have epilepsy. The study, published in January in the online...
by Sue Robbins | May 29, 2013 | Headache Drugs
Mary Pipher, is the author of the bestselling book Reviving Ophelia and, most recently, The Green Boat: Reviving Ourselves in Our Capsized Culture. She recently wrote an article for More magazine, describing a challenging time in her life when a physical ailment...
by Sue Robbins | Apr 10, 2013 | Headache Drugs
Medication-overuse headache (MOH) happens when chronic headache patients see a worsening of their headaches, and react by using more acute medication, including NSAIDs and triptans. This in turn can exacerbate the headaches rather than ease the pain. MOH is defined by...
by Sue Robbins | Mar 24, 2013 | Headache Drugs
A small study led by researchers at Johns Hopkins that looked at women with migraine has been published in the March issue of the journal Headache. “This study takes the first steps in identifying a potential biomarker for migraine that predicts treatment...
by Sue Robbins | Mar 22, 2013 | Headache Drugs
Monster Energy Corporation recently joined the American Beverage Association, which has recommended it sell it’s products as a food, rather than as dietary supplements. While the content of the products will not change, it’s labels will begin to include...